Skip to content

Royalty Pharma plc

RPRX Nasdaq SEC CIK 1802768

Follow Royalty Pharma Weekly email: filings, results, news

News

9 stories filed under Royalty Pharma

Markets

Thread · 4 stories

Royalty Pharma plc (RPRX) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Markets 1 d ago also on BAC

Royalty Pharma expects modest return despite pelacarsen trial failure

Markets 20 d ago 3 sources

Royalty Pharma (RPRX) Bets $100M On A Blood Disorder Breakthrough

Markets 23 d ago

Royalty Pharma stock hits all-time high at 62.48 USD

Markets 23 d ago

More coverage

Royalty Pharma: Strong Execution, Higher Guidance, And Room For A Re-Rating

Earnings 29 d ago

Royalty Pharma: The Quiet Compounder The Market Is Still Mispricing

Markets 29 d ago

Royalty Pharma stock hits all-time high at 60.44 USD

Markets 34 d ago 3 sources

Royalty Pharma EVP & CFO Terrance Coyne sells $645k in shares

Markets 38 d ago

Royalty Pharma plc (RPRX) vs. AstraZeneca PLC (AZN): Which Biopharma Model Offers the Better Growth Story?

Markets 42 d ago also on AZN

Profile

Headquarters: NEW YORK, NY, United States
Sector: Healthcare
Industry: Pharmaceutical Preparations

Peers

Where this page comes from

Profile · SEC EDGAR

News · 9 stories clustered from the RSS aggregator